Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcomes at 5 years post-transplant in imlifidase-desensitized kidney transplant patients.
Jordan SC, Maldonado AQ, Lonze BE, Sjöholm K, Lagergren A, Montgomery RA, Runström A, Desai NM, Legendre C, Lundgren T, von Zur Mühlen B, Vo AA, Tollemar J, Lefèvre P, Lorant T. Jordan SC, et al. Am J Transplant. 2024 Dec 4:S1600-6135(24)00742-1. doi: 10.1016/j.ajt.2024.11.029. Online ahead of print. Am J Transplant. 2024. PMID: 39643005 No abstract available.
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes).
Jordan SC, Legendre C, Desai NM, Lorant T, Bengtsson M, Lonze BE, Vo AA, Runström A, Laxmyr L, Sjöholm K, Schiött Å, Sonesson E, Wood K, Winstedt L, Kjellman C, Montgomery RA. Jordan SC, et al. Transplantation. 2021 Aug 1;105(8):1808-1817. doi: 10.1097/TP.0000000000003496. Transplantation. 2021. PMID: 33093408 Free PMC article. Clinical Trial.
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.
Kjellman C, Maldonado AQ, Sjöholm K, Lonze BE, Montgomery RA, Runström A, Lorant T, Desai NM, Legendre C, Lundgren T, von Zur Mühlen B, Vo AA, Olsson H, Jordan SC. Kjellman C, et al. Among authors: jordan sc. Am J Transplant. 2021 Dec;21(12):3907-3918. doi: 10.1111/ajt.16754. Epub 2021 Jul 19. Am J Transplant. 2021. PMID: 34236770 Free PMC article. Clinical Trial.
Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy.
Pinelli DF, Zachary AA, Friedewald JJ, Gjertson DW, Evans MA, Chatroop EN, Leffell MS, Vo AA, Jordan SC, Montgomery RA, Tambur AR. Pinelli DF, et al. Among authors: jordan sc. Am J Transplant. 2019 Feb;19(2):381-390. doi: 10.1111/ajt.15007. Epub 2018 Aug 23. Am J Transplant. 2019. PMID: 29981209 Free article.
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.
Halleck F, Böhmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sjöholm K, Runström A, Lefèvre P, Tollemar J, Jordan S. Halleck F, et al. Clin Transplant. 2024 Jul;38(7):e15383. doi: 10.1111/ctr.15383. Clin Transplant. 2024. PMID: 39023092 Clinical Trial.
370 results